Serum Lipopolysaccharide-binding Protein Levels and the Incidence of Metabolic Syndrome in a General Japanese Population: the Hisayama Study-Reference-Cited by-同舟云学术

Serum Lipopolysaccharide-binding Protein Levels and the Incidence of Metabolic Syndrome in a General Japanese Population: the Hisayama Study

Published:2022 Issue: Volume: Page:
ISSN:0917-5040
Container-title:Journal of Epidemiology
language:en
Short-container-title:Journal of Epidemiology

Author:

Tomooka Shoko¹^ORCID,Oishi Emi¹^ORCID,Asada Masako¹,Sakata Satoko¹^ORCID,Hata Jun¹^ORCID,Chen Sanmei²^ORCID,Honda Takanori¹^ORCID,Suzuki Kosuke³,Watanabe Hiroshi³,Murayama Norihito³,Wada Naohisa⁴,Kitazono Takanari⁵^ORCID,Ninomiya Toshiharu¹^ORCID

Affiliation:

1. Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University

2. Global Health Nursing, Graduate School of Biomedical and Health Sciences, Hiroshima University

3. Research Institute, Suntory Global Innovation Center Ltd

4. Department of General Dentistry, Faculty of Dental Science, Kyushu University

5. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University

Publisher

Japan Epidemiological Association

Subject

General Medicine,Epidemiology

Link

https://www.jstage.jst.go.jp/article/jea/advpub/0/advpub_JE20220232/_pdf

Reference37 articles.

1. 1. Alberti KG, Eckel RH, Grundy SM, et al; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.

2. 2. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109:551–556.

3. 3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428.

4. 4. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867.

5. 5. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:2227–2236.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Plasma Lipopolysaccharide Concentration and Health Status in Healthy Subjects and Patients with Abnormal Glucose Metabolism in Japan: A Preliminary Cross-Sectional Study;J;2023-11-30